Sign in

CIK 0001087294

  • Non-accelerated filer
  • Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
Operating
EIN
621765329
Phone
+1 615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-11-20 Krogulski Kenneth Director Purchase +3,300 $7.55 $25K 154,300
2017-08-23 Bonner Michael Chief Financial Officer Purchase +500 $6.72 $3K 15,447
2017-05-31 Bonner Michael Chief Financial Officer Purchase +300 $6.95 $2K 14,947
2017-03-23 Bonner Michael Chief Financial Officer Purchase +900 $6.42 $6K 12,800
2017-03-21 Krogulski Kenneth Director Purchase +15,000 $6.53 $98K 150,000
2016-11-17 Bonner Michael Chief Financial Officer Purchase +900 $5.50 $5K 11,900
2011-03-16 JACOBS JOEY A Director Purchase +12,643 $5.04 $64K 50,000
2011-03-15 JACOBS JOEY A Director Purchase +14,319 $5.14 $74K 37,357
2011-03-14 JACOBS JOEY A Director Purchase +23,038 $5.22 $120K 23,038
2010-05-28 Jones James Director Purchase +3,000 $6.90 $21K 3,000
2010-05-25 Edwards Robert Director Purchase +5,900 $6.80 $40K 306,098
2010-05-25 Pavliv Leo Sr. Vice President, Operations Purchase +5,000 $6.78 $34K 20,145
2010-05-24 KAZIMI A J Chairman and CEO Purchase +15,500 $6.66 $103K 5,440,845

Page 138 of 138 · 2,753 trades